Purpose of review Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder (FGID) encountered by the pediatrician and consultant. The primary focus of this review is to provide an update on beneficial nutritional interventions for managing this patient population with discussion on gut microbiome effects.
INTRODUCTION
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder (FGID) characterized by chronic or recurrent gastrointestinal symptoms not attributed to an underlying structural or biochemical disorder [1 & ]. Defined by the Rome III criteria for FGID, IBS is estimated to affect up to 20% of school-age children [2] and accounts for nearly 30% of all consultations to pediatric gastroenterologists with costly workups approximating $6000 per child [3] . IBS is defined as abdominal pain occurring at least once a week for a minimum of 2 months prior to diagnosis. The abdominal pain or discomfort is associated with two or more of the following occurring at least 25% of the time: symptomatic improvement with defecation, onset associated with changes in stool appearance, and/or onset associated with change in stool frequency without an underlying organic cause [2, 4] . There are three clinical subtypes of IBS which include: diarrhea predominant, constipation predominant, and alternating diarrhea and constipation [2] .
Although cause of FGID is uncertain, it is believed to be multifactorial including: visceral hypersensitivity, abnormal motility, low-grade mucosal inflammation, psychosocial stressors, abnormal/altered gut microbiome, and/or environmental triggers such as diet (Fig. 1) . IBS is also considered a brain-gut disorder, hypothesized as an element of dysregulation between the enteric nervous system and central nervous system resulting in altered gut sensation, motility, and potential immune dysfunction [5] .
Most children present with recurrent periumbilical abdominal pain, which is classically relieved following defecation. Associated symptoms include bloating, incomplete evacuation, and fecal urgency. A detailed history and physical exam is essential to making a correct diagnosis of IBS. Ruling out red flag symptoms, including nighttime symptoms, recurrent fever, hematochezia, arthralgia, weight loss, poor growth, delayed puberty, severe vomiting or diarrhea, or steatorrhea is important as these would suggest an underlying organic disorder requiring further evaluation. As an underlying history of anxiety and emotional stress may precipitate symptoms, eliciting a detailed psychological history to uncover areas of stress that may be aggravating symptoms, including bullying, school workload, or upcoming tests, parental discord, or financial difficulties, should be included [6] . Functional abdominal pain significantly affects patient's quality of life, ability to perform activities of daily living, and has a negative impact on social involvement and can affect school performance given frequent absenteeism.
Clinical evaluation
Baseline laboratories to rule out more potentially serious disorders should be obtained. This includes serology to screen for celiac disease; inflammatory markers [erythrocyte sedimentation rate and C-reactive protein (CRP)] to assess for inflammatory
KEY POINTS
More prospective, high-quality, randomized studies are warranted to determine the efficacy, utility, and impact on growth and development with these nutritional interventions in pediatric patients with IBS and other FGIDs.
Long-term follow-up is required to determine the safety and effectiveness of probiotics in the pediatric IBS population.
Dietary interventions and/or elimination diets should be implemented with caution in the pediatric population neither to compromise growth and development nor create food aversions or eating disorders. Nutritional consultation with a registered dietitian is highly recommended. bowel disease (IBD); complete metabolic panel to evaluate liver function and nutritional status; and complete blood count as anemia may indicate blood loss in the setting of IBD. Depending on patient presentation, stool studies may be warranted to rule out infectious causes of diarrhea. Difficult cases in which diagnosis is unclear may warrant endoscopy or imaging [2] .
MANAGEMENT OF IRRITABLE BOWEL SYNDROME

Medical management of irritable bowel syndrome
Currently, standard medical management incorporates dietary advice, reassurance, and education [6] . This review focuses on the role of nutritional interventions for managing IBS and potential effects on the gut microbiome.
Nutritional interventions for irritable bowel syndrome
Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet Limiting fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) (Fig. 2) is a dietary approach utilized to ameliorate IBS-associated symptoms. Diet implementation involves two phases: strict reduction of all dietary FODMAP followed by a gradual reintroduction based on gastrointestinal symptom analysis (Table 1) . In sensitive people, FODMAP are proposed to stimulate mechanoreceptors in response to luminal distention induced by an osmotic effect and increased luminal water due to malabsorption of lactose, fructose, and polyols, and luminal gases (carbon dioxide and hydrogen) from oligosaccharide fermentation. FODMAP intolerance leads to abdominal bloating, pain, and altered motility [7] . Although emerging evidence supports altered FODMAP diet in improving IBS symptoms in adults, skepticism remains due to limited studies comparing low FODMAP with the Western diet. Halmos et al. [8] conducted a randomized, controlled, singleblind, cross-over trial consisting of 30 IBS patients and eight healthy controls. Patients were randomized to a Western or FODMAP diet for a period of 21 days, then crossed over to the alternative diet which was preceded by a 21-day washout period. In contrast to the Western diet, IBS patients following a low FODMAP diet had less overall gastrointestinal symptoms (e.g., bloating, pain, flatulence, and stool consistency). Although data regarding FODMAP diet for IBS in pediatrics is limited, it is promising. School-age children (aged 7-17 years) following a low FODMAP diet for 2 days exhibited less frequency and severity of abdominal pain episodes and total composite gastrointestinal score compared with a Western diet [9 && ].
There is concern with following restrictive diets in the pediatric population as this can lead to food aversions, eating disorders as well as imbalanced nutrient intake, which may compromise growth and development. Children under the age of 10 years have a reduced capacity to absorb fructose, and yet this age group typically consumes large amounts in the form of fruit and/or fruit juices as well as highfructose corn syrup. Limiting this ingredient alone or in combination with other culprits may be an effective approach to alleviate IBS symptoms in pediatrics [10] .
Specific carbohydrate diet in patients with irritable bowel syndrome and inflammatory bowel disease A diet high in refined sugars and processed foods, triggering an abnormal immune response is postulated to have contributed to the rise in pediatric IBD over the past 60 years [11] . Some studies have demonstrated the protective effects of a diet high in fruits, vegetables, and fiber [12] . The specific carbohydrate diet (SCD) claims to assist with drug-free remission in IBD patients by limiting carbohydrate consumption to only monosaccharides, thus most polysaccharides (linear or branch-chained multiple sugars or starches) and disaccharides are eliminated. The premise of SCD is that in IBD alterations in mucosal integrity and digestive enzymes compromise polysaccharide digestion, which results in small intestinal inflammation and gastrointestinal symptoms such as bloating because of excessive fermentation and gas production. By limiting the diet to monosaccharides, polysaccharide digestion is minimized [13] .
Currently, there are no large-scale studies reporting the use of SCD in the pediatric population. A case series performed by Suskind et al. [13] followed seven pediatric patients with Crohn's disease who were not on immunosuppressive agents over a 3-month period. After following a strict SCD, these patients showed symptom improvement as demonstrated on the pediatric Crohn's disease activity index and significant improvement in laboratory parameters, including albumin, CRP, hematocrit, and stool calprotectin. In a retrospective chart review conducted at a single academic center, Obih et al. analyzed the effect of the SCD in their IBD population (20 with Crohn's disease and six with ulcerative colitis). Patients adhered to a SCD for between 3 and 48 months. At the end of the intervention, 12 patients had reduced inflammatory markers as well as exhibited clinical improvement. Some patients were able to discontinue medications and maintain control of their disease on the SCD alone [14 & ]. There are challenges posed by the SCD as it is very carbohydrate restrictive and difficult for many to maintain; therefore, the diet is sometimes liberalized to expand dietary options. However, adding new foods may increase the risk for potentially worsening disease activity. More studies are needed to evaluate liberalizing the diet without causing adverse clinical outcomes.
Mediterranean diet
Rather than focusing on individual nutrients or food properties, another dietary approach for relieving FGID is to alter dietary food patterns. The Mediterranean diet contains foods and eating habits typical of people residing along the Mediterranean Sea (Fig. 3) [15] . Foods are consumed more frequently (up to six times per day) in smaller quantities and include fiber-rich foods such as fresh fruits, vegetables, whole grains, nuts, and legumes, milk or dairy products, and low consumption of meat or meatbased products. Thus, saturated fat is limited with the majority of dietary fat being monounsaturated (olive oil) and omega-3 fatty acids (fish). In contrast, the Western diet (Fig. 3) is low in fiber and high in simple sugars, processed meats, and saturated fats. Evaluations of the effect of the Mediterranean diet on incidence of chronic diseases in adults (e.g., malignancy, type 2 diabetes, metabolic and cardiovascular disease) find populations that adopt this eating pattern have reductions in all-cause mortality [16] [17] [18] . Recently, Zito et al. [19 && ] prospectively analyzed the relationship of upper and lower gastrointestinal symptoms with adherence to the Mediterranean diet in a group of 1134 patients residing in southern Italy. Based on Rome III questionnaire, patients were grouped as those with IBS, functional dyspepsia, or no symptoms (controls). Patients were then further classified into age groups: 17-24, 25-34, 35-49, 50-64, and more than 64 years old. An age-appropriate food frequency questionnaire was used to assess Mediterranean diet adherence and scored as very low, intermediate, and optimal adherence. Of interest, the younger patients, age groups 17-24, had lower Mediterranean diet adherence scores, which was associated with higher incidence of IBS and functional dyspepsia, particularly among women; lower Mediterranean diet adherence scores in this age grouping of men was associated with functional dyspepsia. Analyzing the age 25-34-year age group found that only men and women with IBS had lower Mediterranean diet adherence scores compared with controls. The older age groupings reported higher Mediterranean diet adherence despite presence of gastrointestinal symptoms. As the aging process comes with many other factors that can influence gastrointestinal symptoms, it is not surprising that the older age groups continued with gastrointestinal symptoms despite Mediterranean diet adherence. Young people are more apt to eat convenience foods with higher fat, which have delayed gastric emptying and may aggravate gastrointestinal hypersensitivity. As the Mediterranean diet is more liberalized in allowed foods compared with previously described diets, these data suggest the Mediterranean diet may be a feasible option in this patient population and with proper education adherence may improve. However, more prospective studies comparing different dietary interventions, including the Mediterranean diet, are required in the full age range of the pediatric patient population.
The gut microbiota and irritable bowel syndrome Appreciation for the role the gut microbiota plays in maintaining intestinal homeostasis is growing. Although many factors influence gut microbiota composition, it's response to diet is astounding. As fermentable soluble fiber is the preferred food source for the gut microbiota, not surprisingly, the lowfiber containing Western diet negatively alters gut microbial patterns [20 & ]. Animal and human ex-vivo models investigating dietary emulsifiers, including carboxymethylcellulose, polysorbate-80, and maltodextrin, negatively impact gut microbial balance as well as induce metabolic syndrome and low-grade inflammation leading to colitis [21 & ,22] . Given these findings, the gut microbiota has been implicated in the pathogenesis of IBS [23] .
Chumpitazi et al. [9 && ] evaluated the gut microbiota and symptomatic (pain) response in children with IBS when randomized to a low and high FODMAP diet for 2 days. Patients were categorized as responders, nonresponders, and placeboresponders. An abundance of baseline taxa known as carbohydrate fermenters (Bacteroides, Ruminoccus, Faecalibacterium prausnitzii) was found in the responder group. Authors concluded that patients with IBS with saccharolytic-enriched microbiota may benefit most from a low FODMAP diet. It is important to only limit aggravating FODMAP rather than all FODMAP as the latter could have negative long-term outcomes on the microbiome and theoretically intestinal integrity. This was evidenced in a study that found a low FODMAP diet, whereas improving IBS symptoms, also depleted levels of butyrate-producing bacteria from Clostridium cluster XIVa and mucus-associated bacteria [24 && ].
Probiotics and irritable bowel syndrome Challenges with using modification of gut microbiota to alleviate IBS-related gastrointestinal symptoms surrounds the fact that the exact cause of IBS as well as a 'normal' gut microbiota pattern are A nutritional approach for managing irritable bowel syndrome Bhesania and Cresci undefined. Nonetheless, investigations for probiotic use in alleviating IBS symptoms for abdominal pain and discomfort, bloating and flatulence, bowel habits, gut motility, and quality of life have been conducted. A recent meta-analysis with a total of 1793 patients included randomized controlled trials comparing probiotics with a placebo for altering IBS symptoms [25 & ]. Overall, the responder rate for abdominal pain, global symptom, and general symptom's scores were improved in the probiotic groups compared with placebo. Study limitations include utilization of various IBS symptom scoring systems as well as various strains, doses, and duration of probiotic treatments across the studies, making it challenging to fully appreciate probiotic effects. A systematic review published in 2014 reviewed the effect different probiotic strains had in relation to FGID in children and adolescents [26] . This review concluded that in children with IBS the use of Lactobacillus GG, L. reuteri DSM17 939, and VSL#3 helped reduce the intensity of abdominal pain. Overall, probiotics may be helpful in the IBS population, but further studies are required to determine specific species, strains, and dose required to produce optimal results.
CONCLUSION
Dietary manipulation is becoming common practice for functional abdominal pain and emerging studies suggest symptomatic improvement with the above mentioned dietary interventions in pediatrics, but most of what is currently known has been extrapolated from the adult literature. Evidence to recommend initiating a low FODMAP diet as a primary intervention in pediatrics is growing; however, more long-term prospective studies are required to determine efficacy and any potential associated risks with this dietary approach in pediatric patients with IBS. Although the initial phase of strict FODMAP limitations has been found to be helpful in reducing IBS symptoms, sustainability of these effects following reintroduction of FOD-MAPS is less robust. Therefore, as evidence-based practice guidelines for managing FGID with diet in pediatrics are not currently available, using a sensible approach is suggested. Diagnosing FGID and managing symptoms is preferred over subjecting children to excessive hydrogen breath testing for diagnosis and thus labeling of specific food intolerances. As to be mindful about the importance of optimal nutrition to promote growth and development, a balanced dietary approach is advised. This includes eating regular meals and snacks that comprise a variety of foods from all food groups avoiding excessive amounts and limiting processed foods, such as with the Mediterranean diet dietary pattern. Involving a dietitian familiar with IBS to obtain a thorough nutrition history so that IBS trigger foods can be identified and an age-appropriate meal plan can be developed and monitored is suggested. If IBS symptoms are persistent and an eating disorder or aversion is not suspected, a low FODMAP diet may be implemented under expert supervision (physician and dietitian) for a limited time ( 6 weeks) followed by careful reintroduction of high-FODMAP foods.
